ESG-1-60

N/A

Report date: 2024/10/24 15:14:14
NME

Base Information

Drug NameESG-1-60
Drug Alias NameESG-1-60
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D3 receptor antagonists
TargetsDopamine D3 receptor
Therapy Area/IndicationsCocaine-Related Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsCocaine-Related Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A